Pharmafile Logo
Pharmafocus logo
Advanced Search

opioids

Showing 15 posts of 86 posts found.

800px-fentanyl_patch_packages

Insys Therapeutics founder John Kapoor found guilty of bribing doctors

May 3, 2019
Medical Communications Insys Therapeutics, John Kapoor, Subsys, fentanyl, opioid crisis, opioids, pharma

The founder of opioid drugmaker Insys Therapeutics has been found guilty of bribing doctors in order to persuade them to …

News
636674328233382711-sd-071718-opioids-b-metro

Former pharma wholesaler execs face criminal charges over opioid crisis

April 24, 2019
Research and Development Litigation, RDC, Rochester Drug Cooperative, opioid crisis, opioids

Laurence Doud III, the former CEO of New York-based Rochester Drug Co-operative (RDC) – one of the largest drug distributors …

News
opioid_pills

Opioid crisis cost US government nearly $38 billion in lost taxes

April 11, 2019
Medical Communications, Research and Development US, government, opioid crisis, opioids, public health, tax revenue

The opioid epidemic may have cost US state and federal governments as much as $37.8 billion in lost tax revenue, …

News
suboxone_sl_tabs

Indivior shares fall by 70% after allegations of fraud

April 10, 2019
Research and Development Virginia, indivior, opioid crisis, opioids, suboxone

Shares in London-listed Indivior plummeted this morning after US Federal prosecutors said the British drugmaker had deceived doctors as to …

News
920x920

Sacklers file motion to throw lawsuit out of court

April 5, 2019
Medical Communications Massachusetts, OxyContin, Purdue Pharma, opioid crisis, opioids, sackler

Members of the Sackler family have asked a judge to throw a lawsuit – filed by Massachusetts attorney general Maura …

News
920x920

Sacklers fraudulently transferred funds to dodge litigation, lawsuit says

March 29, 2019
Medical Communications Litigation, New York, OxyContin, Purdue Pharma, Sackelr, opioids

New York state prosecutors have filed a lawsuit against members of the Sackler family, alleging the Purdue Pharma controllers fraudulently …

News
5204602349_c87b204860_z

Specialists petition FDA over opioid approval process

March 22, 2019
Medical Communications FDA, approval process, opioid crisis, opioids, painkillers

FDA officials have called on the federal agency to halt the approval of new narcotic painkillers. Dr Sidney Wolfe, a …

News

NICE to set out new opioid prescription guidelines for GPs

March 18, 2019
Sales and Marketing GPs, NICE, addiction, addictive drugs, opioids, prescription drugs, withdrawal

NICE is set to develop new guidelines for GPs and healthcare professionals setting out rules for doctors regarding opioids and …

News
920x920

Purdue Pharma vow not to profit from fast tracked opioid overdose antidote

March 18, 2019
Sales and Marketing FDA, OxyContin, Purdue Pharma, nalmefene hydrochloride, opioids

The FDA has granted OxyContin drugmaker Purdue Pharma, fast track designation for opioid overdose antidote nalmefene hydrochloride (HCl) injection. However, …

News
opioid_pills

Reformulated OxyContin led to spike in Hepatitis C infections

February 5, 2019
Manufacturing and Production OxyContin, USA, hepatitis C, heroin, infectious diseases, opioids

Efforts to create an “abuse deterrent” OxyContin pill inadvertently led to an increase in the number of Hepatitis C infections, …

News
920x920

Purdue Pharma sought to expand into opioid addiction treatments while using McKinsey to counter “emotional messages”

January 31, 2019
Business Services, Medical Communications Massachusetts, OxyContin, Purdue Pharma, US, USA, opioids

OxyContin drugmaker Purdue Pharma explored expanding into the market for opioid addiction treatments, according to passages from court documents that …

News
920x920

Opioid drugmaker Purdue Pharma inks deal with Alivio over non-opioid inflammation drug

January 29, 2019
Manufacturing and Production Alivio, Purdue Pharma, health, inflammation, opioids

Opioid drugmaker Purdue Pharma has entered into an agreement with inflammatory disease specialist Alivio Therapeutics for the development of the …

News
dw-anzcxqaqavhl

Head of opioid advisory panel criticises FDA for complacency in ongoing crisis

January 28, 2019
Medical Communications, Sales and Marketing Dsuvia, FDA, opioid crisis, opioids, pharma

The opioid crisis continues to be a top healthcare concern in the US, but the head of the FDA’s Anesthetic …

News

FDA rejects Mallinckrodt’s abuse-deterrent version of opioid painkiller Roxicodone

December 12, 2018
Research and Development, Sales and Marketing FDA, Mallinckrodt, Roxicodone, opioid crisis, opioids, pharma

Mallinckrodt has hit a snag in its quest to bring an abuse-deterrent version of Roxicodone (oxycodone hydrochloride) to market in …

News
fda2outsideweb

FDA approves first prescription mobile app for opioid use disorder, courtesy of Sandoz and Pear Therapeutics

December 11, 2018
Manufacturing and Production, Sales and Marketing FDA, Novartis, Pear Therapeutics, app, opioid crisis, opioid epidemic, opioids, pharma, reSET-o

A digital therapeutic launched by Pear Therapeutics and Novartis’ generics and biosimilars division Sandoz has become the first FDA-approved app …

News

Latest content

Eisai and Biogen’s Leqembi launched for Alzheimer’s treatment in China

June 28, 2024

AbbVie’s Tepkinly gains positive CHMP opinion for follicular lymphoma treatment

June 28, 2024

IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer

June 27, 2024

Immunotherapy created at Roswell Park Comprehensive Cancer Center given expanded ODD by FDA

June 27, 2024

Abcuro completes enrolment for phase 2/3 IBM treatment trial

June 26, 2024